BIOHIT secures European distribution rights for Biomedal’s gluten immunogenic peptide tests

BIOHIT is excited to announce an agreement with Biomedal to supply its iVYLISA, iVYCHECK and GlutenDetect gluten immunogenic peptide (GIP) tests.

New blood test identifies obesity-related health risks in children

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes,

September 20, 2024

Pangolins’ genetic makeup linked to increased coronavirus susceptibility

Research reveals pangolins’ vulnerability to coronavirus due to innate immune gene pseudogenization, impacting their antiviral response.

January 10, 2024

Headspace plans to be cash-flow positive in the first quarter of 2024

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) SAN FRANCISCO — Despite a $3 billion

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.